Biometrics are best defined as measurable physiological and / or behavioral characteristics that can be utilized to verify the identity of an individual. They are of interest in any area where it is important to verify the true identity of an individual. Initially, these techniques were employed primarily in specialist high security applications, however we are now seeing their use and proposed use in a much broader range of public facing situations. Biometrics measure individuals' unique physical or behavioral characteristics to recognize or authenticate their identity. Common physical biometrics include fingerprints; hand or palm geometry; and retina, iris, or facial characteristics. Behavioral characters include signature, voice (which also has a physical component), keystroke pattern, and gait. Of this class of biometrics, technologies for signature and voice are the most developed. Now a days the biometrics technology is preferred by many organization for the security purpose and in coming future we will see the same technology in ATM machine, telephone transactions, internet transactions and so on.
Biometrics are not a future technology, they are a current technology, with a bigger role in the future. Biometrics will not to replace passwords, swipe cards, or pin numbers etc, rather work with them in enhancing security in a simple, reliable, and cost effective way.
- INSILICO BINDING ANALYSIS OF SCH
66336-DERIVATIVE WITH FARNESYLTRANSFERASE
- MOLECULAR MODELING AND DOCKING STUDY OF ACHE
INHIBITOR €Œ HELICID DERIVATIVE
- MOLECULAR DOCKING STUDY OF STYRYLQUINOLINE
WITH HIV-INTEGRASE
- HIGH THROUGHPUT VIRTUAL SCREENING USING CDK-2
- MOLECULAR DOCKING STUDY OF 1H-PYRAZOLE
DERIVATIVE WITH COX-2
- HIGH THROUGHPUT SCREENING OF ANTICANCER
TARGETS USING HSP90
- MOLECULAR DOCKING STUDY OF NAPHTHYL
BENZISOXAZOLE DERIVATIVE WITH ESTROGEN RECEPTOR-BETA
- MOLECULAR DOCKING STUDY OF ANTICANCER DRUGS
WITH HDAC
- MOLECULAR DOCKING STUDY OF THIOUREA DERIVATIVE
WITH NEURAMINIDASE
- MEDICNAL PLANT DATABASE
- HOMOLOGY MODELING OF TARGET PROTEINS / ENZYMES
USING MODELLER9V4
- ACTIVE
SITE ANALYSIS BY MUTATION AND MOLECULAR DOCKING PROCESS
- CONFORMATIONAL ANALYSIS OF PROTEIN / ENZYME
USING GROMACS-3.3.1
- HTVS OF NCI-DIVERSITY FOR P53 USING DOCK6.1
- MOLECULAR DOCKING STUDIES USING AUTODOCK-3.1
0 comments:
THANKS FOR UR COMMENT ....